The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
LetterFull Access

Women's Health Needs

Published Online:https://doi.org/10.1176/ps.49.11.1493-a

In Reply: The authors misread my commentary. I don't argue for bringing women's health into the mainstream: women's health is the mainstream. Women buy more pharmaceuticals and go to the doctor more often than men. They live seven years longer and thus are overrepresented among the greatest consumers of health care, the elderly.

True, women of childbearing age had been omitted from phase 1 and phase 2 clinical trials (the safety phases), but they were always well represented in the actual efficacy, or phase 3, trials.

An additional point is that when prescribing medicines, physicians frequently adjust dosages and start at low levels for both sexes. Individual differences within sexes can be greater than individual differences between sexes. Making the necessary adjustments requires hands-on clinical experience.